News
- 2024.05.08
- SymBio Announces Initiation of Phase 2a Clinical Trial (ATHENA) of Intravenous Brincidofovir for Treatment of Cytomegalovirus Infection after Hematopoietic Stem Cell Transplantation
- 2024.05.08
- 四半期報告書-第20期第1四半期(2024/01/01-2024/03/31) (Japanese only)
- 2024.05.07
- Summary of Consolidated Financial Statements for the First Three Months of Fiscal Year Ending December 31, 2024 [Japanese GAAP]
- 2024.05.07
- Revision to Earnings Forecast for FY 2024
- 2024.04.19
- Notice regarding the Issuance of Stock Acquisition Rights (Stock Options) to the Company’s Directors
Selection News
- 2024.03.26
- 「動画で観るシンバイオ製薬」を更新しました。(Japanese only)
- 2024.03.26
- 第19期定時株主総会の動画を掲載しました。(Japanese only)
- 2024.02.20
- Article on 2023 Earnings Call Featured in Nikkei Biotech Online (Japanese only)
Source: Nikkei Biotech ONLINE, 2024.02.15
Although Nikkei BP grants permission to use the articles, the content of the articles does not constitute a recommendation to purchase/invest in a specific company/organization or product/service.
Unauthorized reproduction, duplication, or electronic storage of the articles/photos/charts, etc. is prohibited.
- 2024.02.16
- 2023年12月期決算説明会の動画を掲載しました。(Japanese only)
- 2024.02.14
- 決算説明会資料(2023年12月期)(Japanese only)
- 2023.11.17
- Notice of Relocation of Head Office